8-K
Current Report
Celldex Therapeutics, Inc. Filed Acc 0001104659-05-012417
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading a05-5567_18k.htm…